Early and out‐of‐hospital use of COVID‐19 convalescent plasma: An international assessment of utilization and feasibility

Background and Objectives The use of coronavirus disease 2019 (COVID‐19) convalescent plasma (CCP) in the treatment of patients with severe acute respiratory syndrome‐2 infection has been controversial. Early administration of CCP before hospital admission offers a potential advantage. This manuscri...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vox sanguinis 2022-10, Vol.117 (10), p.1202-1210
Hauptverfasser:	Al‐Riyami, Arwa Z., Estcourt, Lise, Rahimi‐Levene, Naomi, Bloch, Evan M., Goel, Ruchika, Tiberghien, Pierre, Thibert, Jean‐Baptiste, Bruun, Mie Topholm, Devine, Dana V., Gammon, Richard R., Wendel, Silvano, Toungouz Nevessignsky, Michel, Grubovic Rastvorceva, Rada M., Oreh, Adaeze, Romon, Iñigo, Berg, Karin, Kitazawa, Junichi, Patidar, Gopal, So‐Osman, Cynthia, Wood, Erica M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood transfusion Clinical trials convalescent plasma Coronaviruses COVID-19 COVID-19 - therapy COVID-19 Serotherapy Feasibility Feasibility Studies home transfusion Hospitals Humans Immunization, Passive - adverse effects Legislation Original Pandemics SARS-CoV-2 Severe acute respiratory syndrome Transfusion Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!